Therefore, identification of these modifying factors, which might explain inconsistencies in the field, will be crucial to generate an adequate cellular LRRK2 PD model, which (at least partly) recapitulates the pathological mechanisms in patients and thus provides a reliable platform for new therapeutic strategies. The gene discussed is LRRK2; the disease is Parkinson disease.